Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6118804 | International Journal of Infectious Diseases | 2010 | 6 Pages |
Abstract
The absence of quintuple mutations in the examined isolates supports the continued use of SP as the treatment of choice for uncomplicated malaria as a partner drug to artemisinin combination therapy in Iran. However, the increase in the triple pfdhfr/pfdhps (R59N108/G437) mutant haplotypes indicates that the P. falciparum parasite populations have the potential to evolve into dhfr/dhps quintuple mutants in the near future. Therefore, monitoring the status of dhps alleles as a predictor of the development of clinical resistance to sulfadoxine should be a high priority in this region.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Sedigheh Zakeri, Maryam Shahrabi Farahani, Mandana Afsharpad, Masoud Salehi, Ahmad Raeisi, Navid Dinparast Djadid,